Stay updated on Cabozantinib in HR+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in HR+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in HR+ Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6. This appears to be a minor metadata update and does not modify the study information presented on the page.
    Difference
    0.1%
    Check dated 2026-09-01T19:24:49.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page shows a new revision indicator: v3.6.5, replacing v3.6.4. This reflects an update to the page build rather than any changes to the study content.
    Difference
    0.1%
    Check dated 2026-08-11T08:21:16.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.6.4, signaling a newer revision of the page. This appears to be a maintenance update rather than a substantive change to study information.
    Difference
    0.1%
    Check dated 2026-07-28T04:59:04.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A new page revision label, v3.6.3, was added and the previous label v3.6.2 was removed. This indicates an update to the page's versioning, without changes to the study text or data presented.
    Difference
    0.1%
    Check dated 2026-07-06T16:39:02.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.0 to v3.6.2, signaling a small patch to the page metadata. No changes to the study content are indicated.
    Difference
    0.1%
    Check dated 2026-06-29T08:50:04.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The study page now displays a recruitment status indicating no longer enrolling participants. New help and navigation sections—How to Read a Study Record, Common Questions, and How to Join a Study—are added, alongside a minor label change for Intervention/Treatment and a revision update from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T08:17:48.000Z thumbnail image

Stay in the know with updates to Cabozantinib in HR+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in HR+ Breast Cancer Clinical Trial page.